Dacarbazine

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17756 publications

Tropolone Derivative JO-122(2) Enhances Temozolomide Efficacy and p53-Mediated Apoptosis in Glioblastoma Xenografts.

Tropolone Derivative JO-122(2) Enhances Temozolomide Efficacy and p53-Mediated Apoptosis in Glioblastoma Xenografts.

Journal: Iranian biomedical journal

Published: September 04, 2026

Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.

Successful treatment of refractory hemophagocytic lymphohistiocytosis complicating Epstein-Barr virus-positive classic Hodgkin lymphoma with rituximab.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: August 30, 2026

Multifaceted Temozolomide Toxicity in Glioma: Detection & Care.

Multifaceted Temozolomide Toxicity in Glioma: Detection & Care.

Journal: La Clinica terapeutica

Published: August 28, 2026

Secondary Renal Cell Carcinoma Bearing the Genomic Signature of Prior Temozolomide Therapy.

Secondary Renal Cell Carcinoma Bearing the Genomic Signature of Prior Temozolomide Therapy.

Journal: JCO precision oncology

Published: August 26, 2026

Incidence of clinically significant chemotherapy induced nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis.

Incidence of clinically significant chemotherapy induced nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis.

Journal: Leukemia & lymphoma

Published: August 24, 2026

Preparation of a mechanically biomimetic polymer-infiltrated ceramic and bond test by digital image correlation.

Preparation of a mechanically biomimetic polymer-infiltrated ceramic and bond test by digital image correlation.

Journal: Dental materials journal

Published: August 19, 2026

Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision.

Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision.

Journal: Molecular therapy. Oncology

Published: August 16, 2026

HODGKIN LYMPHOMA DIAGNOSED DURING THE SECOND TRIMESTER OF PREGNANCY AND TREATED WITH ABVD CHEMOTHERAPY WITH FAVORABLE MATERNAL AND NEONATAL OUTCOMES: A CASE REPORT.

HODGKIN LYMPHOMA DIAGNOSED DURING THE SECOND TRIMESTER OF PREGNANCY AND TREATED WITH ABVD CHEMOTHERAPY WITH FAVORABLE MATERNAL AND NEONATAL OUTCOMES: A CASE REPORT.

Journal: Georgian medical news

Published: August 15, 2026

Anaphylactic reaction to the second dose of dacarbazine following initial exposure in patient with hodgkin lymphoma.

Anaphylactic reaction to the second dose of dacarbazine following initial exposure in patient with hodgkin lymphoma.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: August 11, 2026

ECMO as salvage therapy for severe ARDS complicating Crotalus atrox envenomation.

ECMO as salvage therapy for severe ARDS complicating Crotalus atrox envenomation.

Journal: Perfusion

Published: August 11, 2026

Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma.

Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma.

Journal: JCO oncology advances

Published: August 11, 2026

Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy.

Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy.

Journal: Journal for immunotherapy of cancer

Published: August 10, 2026

Showing 1-12 of 17,756

Last Updated: 09/26/2026